XOMA to Announce 2010 Second Quarter Financial Results and Host Webcast Conference Call on August 9, 2010 Aug 02, 2010 8:00am EDT
XOMA 052 Orphan Drug Designation for Behcet's Disease Recommended by European Medicines Agency Jul 29, 2010 8:00am EDT
XOMA Achieves Planned Enrollment Goal for Phase 2b Clinical Trial of XOMA 052 in Type 2 Diabetes Jun 30, 2010 9:00am EDT
Preclinical Results With XOMA 052 in Type 2 Diabetes Presented at American Diabetes Association 70th Scientific Sessions Jun 26, 2010 10:10am EDT
Journal Article in Endocrinology Highlights Preclinical XOMA 052 Data in Type 2 Diabetes Jun 22, 2010 8:00am EDT
